These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3541087)

  • 21. Protective effect of donepezil against Abeta(1-40) neurotoxicity in rat septal neurons.
    Kimura M; Akasofu S; Ogura H; Sawada K
    Brain Res; 2005 Jun; 1047(1):72-84. PubMed ID: 15893738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Animal models of Alzheimer's disease: experimental cholinergic denervation.
    Smith G
    Brain Res; 1988; 472(2):103-18. PubMed ID: 3289686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic brain cytochrome oxidase inhibition selectively alters hippocampal cholinergic innervation and impairs memory: prevention by ladostigil.
    Luques L; Shoham S; Weinstock M
    Exp Neurol; 2007 Aug; 206(2):209-19. PubMed ID: 17580085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer plaques and cortical cholinergic innervation.
    Mesulam MM
    Neuroscience; 1986; 17(1):275-6. PubMed ID: 3960313
    [No Abstract]   [Full Text] [Related]  

  • 25. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya.
    Mufson EJ; Jaffar S; Levey AI
    J Comp Neurol; 1998 Mar; 392(3):313-29. PubMed ID: 9511920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Alzheimer's disease and Meynert's nucleus basalis. An anatomo- clinical point of view].
    Brion S; Plas J; Massé G
    Encephale; 1986; 12(3):111-4. PubMed ID: 3769856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vestibular loss as a contributor to Alzheimer's disease.
    Previc FH
    Med Hypotheses; 2013 Apr; 80(4):360-7. PubMed ID: 23375669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired muscarinic regulation of excitatory synaptic transmission in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Goto Y; Niidome T; Hongo H; Akaike A; Kihara T; Sugimoto H
    Eur J Pharmacol; 2008 Mar; 583(1):84-91. PubMed ID: 18282567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The history of the cholinergic hypothesis.
    Contestabile A
    Behav Brain Res; 2011 Aug; 221(2):334-40. PubMed ID: 20060018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholinergic neural regulation of regional cerebral blood flow.
    Sato A; Sato Y
    Alzheimer Dis Assoc Disord; 1995; 9(1):28-38. PubMed ID: 7605619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer's disease.
    Pomara N; Sidtis JJ
    N Engl J Med; 2010 May; 362(19):1844; author reply 1844-5. PubMed ID: 20463348
    [No Abstract]   [Full Text] [Related]  

  • 32. Cholinergic hypothesis of Alzheimer's disease: biophysical aspects.
    Adams PR
    Res Publ Assoc Res Nerv Ment Dis; 1987; 65():169-85. PubMed ID: 3330840
    [No Abstract]   [Full Text] [Related]  

  • 33. Alzheimer's disease: a disorder of cortical cholinergic innervation.
    Coyle JT; Price DL; DeLong MR
    Science; 1983 Mar; 219(4589):1184-90. PubMed ID: 6338589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is alpha-MSH deficiency the cause of Alzheimer's disease?
    Anderson B
    Med Hypotheses; 1986 Apr; 19(4):379-85. PubMed ID: 3635664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current theories on the etiopathogenesis and treatment of Alzheimer's disease].
    Bidzan L
    Psychiatr Pol; 1986; 20(5):377-85. PubMed ID: 3295924
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacological drug treatment of Alzheimer disease: the cholinergic hypothesis revisited.
    Ladner CJ; Lee JM
    J Neuropathol Exp Neurol; 1998 Aug; 57(8):719-31. PubMed ID: 9720487
    [No Abstract]   [Full Text] [Related]  

  • 37. Biochemistry of Alzheimer's disease: a report.
    Berry IR; Borkan L
    Psychopharmacol Bull; 1985; 21(2):347-55. PubMed ID: 2860697
    [No Abstract]   [Full Text] [Related]  

  • 38. [Alzheimer's disease: etiology, clinical aspects and therapy].
    Haupt M
    Krankenpfl J; 1992 Sep; 30(9):393-8. PubMed ID: 1434479
    [No Abstract]   [Full Text] [Related]  

  • 39. Approaches to cholinergic therapy in Alzheimer's disease.
    Iversen LL
    Prog Brain Res; 1993; 98():423-6. PubMed ID: 8248531
    [No Abstract]   [Full Text] [Related]  

  • 40. Cholinergic modulation of sensory information.
    Rasmusson DD
    Prog Brain Res; 1993; 98():357-64. PubMed ID: 8248524
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.